REQUEST A DEMO
Total
USD $0.00
Search more companies

Osauhing ProtoBioS (Estonia)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Osauhing ProtoBioS Profile Updated: July 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Osauhing ProtoBioS is based in Estonia, with the head office in Tallinn. The enterprise operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was incorporated on November 03, 2003. The latest financial highlights indicate a net sales revenue increase of 138.54% in 2025. There was a total negative growth of 10.5% in Osauhing ProtoBioS’s total assets over the same period. Osauhing ProtoBioS’s net profit margin decreased by 12.48% in 2025.

Headquarters
Maealuse tn 4/1 Mustamae linnaosa
Tallinn; Harju county; Postal Code: 12618

Contact Details: Purchase the Osauhing ProtoBioS report to view the information.

Basic Information
Registered Capital:
Purchase the Osauhing ProtoBioS report to view the information.
Financial Auditors:
Purchase the Osauhing ProtoBioS report to view the information.
Incorporation Date:
November 03, 2003
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
85.02%
Purchase this report to view the information.
10%
Purchase this report to view the information.
4.98%
Company Performance
Financial values in the chart are available after Osauhing ProtoBioS report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
138.54%
Total Operating Revenue
138.54%
Operating Profit
2631.19%
EBITDA
66.42%
Net Profit/Loss for the Period
-52.03%
Total Assets
-10.5%
Total Equity
0.11%
Operating Profit Margin
158.57%
Net Profit Margin
-12.48%
Return on Equity (ROE)
-0.12%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?